ACL Graft Market by Type of ACL Surgery (Reconstruction, Revision), Age (Above & Below 19 years), Gender (Male, Female), Injury (Sports Injuries (Basketball, Football), Non-sports Injuries (Road Accidents, Falls)), End User - Global Forecast to 2029
The global ACL graft market is projected to reach 0.18 billion by 2029 from USD 0.12 billion in 2024, at a CAGR of 7.2% during the forecast period. The growing prevalence of sports and accident-rel... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryThe global ACL graft market is projected to reach 0.18 billion by 2029 from USD 0.12 billion in 2024, at a CAGR of 7.2% during the forecast period. The growing prevalence of sports and accident-related injuries has significantly impacted the demand for ACL grafts. As more individuals engage in high-intensity sports and activities, the risk of ACL injuries increases. This trend is further compounded by the general rise in accident-related injuries, which also contribute to the frequency of ACL damage and hence the demand for ACL grafts.“The ACL revision segment is projected to witness highest growth rate in the ACL graft market, by type of ACL surgery, during the forecast period” Based on type of ACL surgery, the ACL graft market is segmented into primary ACL reconstruction and ACL revision. The ACL revision segment is projected to witness highest growth rate in the ACL graft market during the forecasted period. As the population ages and stays active for longer, there's an increase in ACL injuries among older adults, some of whom require revisions. However, a rise in sports-related injuries, combined with a heightened awareness of treatment options, has led to more ACL repairs. “The above 19 years segment is projected to witness the highest growth rate in the ACL graft market, by age group, during the forecast period.” Based on age group, the ACL graft market is segmented into 19 years and below and above 19 years. The above 19-year segment is projected to witness the highest growth rate in the ACL graft market during the forecasted period. This group, particularly active adults, faces a higher likelihood of sports-related injuries and other physically demanding activities leading to significant number of ACL injuries, contributing to growth of this segment. “The male segment is projected to witness the highest growth rate in the ACL graft market, in 2023, by gender, during the forecast period.” Based on gender, the ACL graft market is segmented into male and female. The male segment is projected to witness the highest growth rate in the ACL graft market during forecasted period. Males are more prone to ACL injuries due to factors like greater involvement in high-impact sports (e.g., football, basketball, rugby) and physically demanding jobs. This drives a higher demand for ACL surgeries and grafts among men during the forecast period. “The sports injury segment is projected to witness highest growth rate in the ACL graft market, by injury type, during the forecast period” Based on injury type, the ACL graft market is segmented into sports injury and non-sports injury. The sports injury segment is projected to witness highest growth rate in the ACL graft market during the forecasted period. With more individuals participating in both professional and recreational sports, there is a corresponding rise in ACL injuries. The growing popularity of organized sports and fitness regimes across the globe continues to fuel the demand for ACL reconstructions. “The Asia Pacific region is projected to witness highest growth rate in the ACL graft market during the forecast period” The global ACL graft market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. The Asia Pacific is projected to register the highest CAGR in the ACL graft market during the forecast period. The high growth in the Asia Pacific market can be attributed to the increasing participation in sports, rising road accidents, and growth in geriatric population and age-related orthopedic complications. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America – 38%, Europe – 26%, Asia Pacific – 15%, Latin America – 11%, Middle East & Africa – 7%, and the GCC Countries – 3% Lists of Companies Profiled in the Report: RTI Surgical (US), AlloSource (US), Arthrex, Inc. (US), LifeNet Health (US), Bone Bank Allografts (US), MTF Biologics (US), Parametrics Medical (US), and JRF Ortho (US). Research Coverage: In this report, the ACL graft market has been categorized based on end user (hospitals & ambulatory surgery centers, and specialty clinics), age group (19 years and below and above 19 years), injury type (sports injury and non-sports injury), type of ACL surgery (primary ACL reconstruction and ACL revision), gender (male and female), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries). Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the ACL graft market's expansion is included in detail in this study. An exhaustive study of the key players in the ACL graft market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging ACL graft startups. Reasons to buy this report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall ACL graft market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restraints. The report provides insights on the following pointers: • Analysis of key drivers: (Rise in the aging population that is more susceptible to orthopedic complications, increase in sports and accident-related injuries, and the rising awareness about ACL injuries along with advancements in surgical techniques and improved graft materials), restraints (High cost of ACL reconstruction surgery, and Risks associated with ACL graft surgery), opportunities (Favourable government initiatives and improved insurance coverage for ACL surgeries, and expansion of healthcare facilities & increased healthcare expenditure), and challenges (Need for skilled professionals, discrepancies in the availability of insurance for ACL Surgeries, and regulatory Hurdles for new medical devices and graft materials) influencing the growth of the in ACL graft market. • Market Development: Comprehensive information about lucrative markets – the report analyses the ACL graft market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ACL graft market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like RTI Surgical (US), AlloSource (US), MTF Biologics (US), Arthrex, Inc. (US), and LifeNet Health (US) are among others, in the ACL graft market strategies. Table of Contents1 INTRODUCTION 221.1 STUDY OBJECTIVES 22 1.2 MARKET DEFINITION 22 1.2.1 INCLUSIONS AND EXCLUSIONS 23 1.3 STUDY SCOPE 24 1.3.1 MARKETS COVERED 24 1.3.2 YEARS CONSIDERED 25 1.4 CURRENCY CONSIDERED 25 1.5 STAKEHOLDERS 25 2 RESEARCH METHODOLOGY 26 2.1 RESEARCH DATA 26 2.1.1 SECONDARY DATA 27 2.1.1.1 Key data from secondary sources 28 2.1.2 PRIMARY DATA 28 2.1.2.1 Primary sources 29 2.1.2.2 Key data from primary sources 29 2.1.2.3 Key industry insights 30 2.1.2.4 Breakdown of primary interviews 31 2.2 MARKET SIZE ESTIMATION 31 2.2.1 BOTTOM-UP APPROACH 31 2.2.1.1 Approach 1: Company revenue estimation approach 32 2.2.1.2 Approach 2: Presentations of companies and primary interviews 33 2.2.1.3 Approach 3: Primary interviews 33 2.2.1.4 Approach 4: Based on number of ACL reconstruction surgeries performed 33 2.2.2 TOP-DOWN APPROACH 35 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 36 2.4 MARKET SHARE ANALYSIS 38 2.5 RESEARCH ASSUMPTIONS 38 2.6 GROWTH RATE ASSUMPTIONS 38 2.7 RESEARCH LIMITATIONS 38 2.7.1 METHODOLOGY-RELATED LIMITATIONS 39 2.7.2 SCOPE-RELATED LIMITATIONS 39 2.8 RISK ASSESSMENT 39 3 EXECUTIVE SUMMARY 40 4 PREMIUM INSIGHTS 45 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ACL GRAFT MARKET 45 4.2 NORTH AMERICA: ACL GRAFT MARKET, BY TYPE OF ACL SURGERY AND COUNTRY (2023) 46 4.3 ACL GRAFT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47 4.4 ACL GRAFT MARKET: REGIONAL MIX (2024–2029) 48 4.5 ACL GRAFT MARKET: DEVELOPED VS. EMERGING MARKETS 49 5 MARKET OVERVIEW 50 5.1 INTRODUCTION 50 5.2 MARKET DYNAMICS 50 5.2.1 DRIVERS 51 5.2.1.1 Rise in aging population that is more susceptible to orthopedic complications 51 5.2.1.2 Increase in sports and accident-related injuries 51 5.2.1.3 Rising awareness of ACL injuries and advancements in surgical techniques and graft materials 52 5.2.2 RESTRAINTS 53 5.2.2.1 High cost of ACL reconstruction surgery 53 5.2.2.2 Risks associated with ACL graft surgery 53 5.2.3 OPPORTUNITIES 54 5.2.3.1 Favorable government initiatives and improved insurance coverage for ACL surgeries 54 5.2.3.2 Expansion of healthcare facilities and increasing healthcare expenditure 54 5.2.4 CHALLENGES 55 5.2.4.1 Need for skilled professionals 55 5.2.4.2 Discrepancies in availability of insurance for ACL surgery 55 5.2.4.3 Regulations for new medical devices and graft materials 56 5.3 PRICING ANALYSIS 56 5.3.1 INDICATIVE PRICING ANALYSIS, BY REGION 56 5.4 VALUE CHAIN ANALYSIS 57 5.5 SUPPLY CHAIN ANALYSIS 59 5.6 ECOSYSTEM ANALYSIS 60 5.6.1 ACL GRAFT MARKET: ROLE OF COMPANIES IN ECOSYSTEM 61 5.7 PORTER’S FIVE FORCES ANALYSIS 61 5.7.1 THREAT OF NEW ENTRANTS 62 5.7.2 THREAT OF SUBSTITUTES 63 5.7.3 BARGAINING POWER OF SUPPLIERS 63 5.7.4 BARGAINING POWER OF BUYERS 63 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 63 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 64 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 64 5.8.2 BUYING CRITERIA 64 5.9 REGULATORY LANDSCAPE 65 5.9.1 NORTH AMERICA 65 5.9.1.1 US 65 5.9.1.2 Canada 65 5.9.2 EUROPE 66 5.9.3 ASIA PACIFIC 66 5.9.3.1 Japan 66 5.9.3.2 India 66 5.9.4 LATIN AMERICA 66 5.9.4.1 Mexico 66 5.9.5 MIDDLE EAST 67 5.9.6 AFRICA 67 5.9.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67 5.10 TRADE ANALYSIS 69 5.10.1 IMPORT DATA 69 5.10.2 EXPORT DATA 69 5.11 PATENT ANALYSIS 70 5.11.1 LIST OF MAJOR PATENTS, 2022–2023 71 5.12 KEY CONFERENCES AND EVENTS IN 2024–2025 71 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 72 5.14 IMPACT OF GENERATIVE ARTIFICIAL INTELLIGENCE (AI) ON ACL GRAFT MARKET 73 6 ACL GRAFT MARKET, BY TYPE OF ACL SURGERY 74 6.1 INTRODUCTION 75 6.2 PRIMARY ACL RECONSTRUCTION 75 6.2.1 HIGH OCCURRENCE OF ACL INJURIES TO DRIVE MARKET 75 6.3 ACL REVISION 77 6.3.1 POTENTIAL FAILURES OF ACL RECONSTRUCTION TO DRIVE MARKET 77 7 ACL GRAFT MARKET, BY AGE GROUP 80 7.1 INTRODUCTION 81 7.2 19 YEARS AND BELOW 81 7.2.1 RISE OF SPORTS-RELATED INJURIES AMONG TEENS TO DRIVE MARKET 81 7.3 ABOVE 19 YEARS 83 7.3.1 TREND OF ACTIVE LIFESTYLES AMONG OLDER ADULTS TO DRIVE MARKET 83 8 ACL GRAFT MARKET, BY GENDER 86 8.1 INTRODUCTION 87 8.2 MALE 87 8.2.1 HIGHER INVOLVEMENT IN CONTACT SPORTS TO DRIVE MARKET 87 8.3 FEMALE 89 8.3.1 GROWING PARTICIPATION OF WOMEN IN SPORTS TO DRIVE MARKET 89 9 ACL GRAFT MARKET, BY INJURY TYPE 92 9.1 INTRODUCTION 93 9.2 SPORTS INJURIES 93 9.2.1 BASKETBALL 96 9.2.1.1 High susceptibility to ACL tears to drive market 96 9.2.2 FOOTBALL 98 9.2.2.1 Surge in knee injuries due to increasing participation to drive market 98 9.2.3 OTHER SPORTS INJURIES 100 9.3 NON-SPORTS INJURIES 102 9.3.1 ROAD ACCIDENTS 105 9.3.1.1 Rise of road accidents globally to drive market 105 9.3.2 FALLS 107 9.3.2.1 Need for surgical interventions to regain knee stability to drive market 107 9.3.3 OTHER NON-SPORTS INJURIES 109 10 ACL GRAFT MARKET, BY END USER 112 10.1 INTRODUCTION 113 10.2 HOSPITALS & AMBULATORY SURGERY CENTERS 113 10.2.1 LARGE PATIENT POOLS TO DRIVE MARKET 113 10.3 SPECIALTY CLINICS 116 10.3.1 TREND OF INNOVATIVE TREATMENT APPROACHES TO DRIVE MARKET 116 11 ACL GRAFT MARKET, BY REGION 119 11.1 INTRODUCTION 120 11.2 NORTH AMERICA 121 11.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 121 11.2.2 US 125 11.2.2.1 Growing demand for ACL surgeries to drive market 125 11.2.3 CANADA 128 11.2.3.1 Growing geriatric population and rise in number of ACL surgeries to drive demand 128 11.3 EUROPE 131 11.3.1 EUROPEAN UNION: MACROECONOMIC OUTLOOK 132 11.3.2 GERMANY 135 11.3.2.1 Increase in road accidents and injuries to boost market 135 11.3.3 UK 138 11.3.3.1 Increased funding for multi-sports facilities to positively impact market 138 11.3.4 FRANCE 141 11.3.4.1 Robust healthcare system and growing geriatric population to boost growth 141 11.3.5 ITALY 144 11.3.5.1 Increase in ACL surgeries to support market growth 144 11.3.6 SPAIN 147 11.3.6.1 Growing participation of people in sports activities to drive market 147 11.3.7 REST OF EUROPE 150 11.4 ASIA PACIFIC 153 11.4.1 EAST ASIA & PACIFIC: MACROECONOMIC OUTLOOK 154 11.4.2 JAPAN 158 11.4.2.1 Rising cases of road accidents and country’s robust healthcare sector to support market 158 11.4.3 CHINA 161 11.4.3.1 Increased public access to modern healthcare facilities to boost demand for ACL grafts 161 11.4.4 REST OF ASIA PACIFIC 164 11.5 LATIN AMERICA 168 11.5.1 RISE IN CASES OF ACCIDENTS TO FUEL ADOPTION OF ACL GRAFTS 168 11.5.2 LATIN AMERICA & CARIBBEAN: MACROECONOMIC OUTLOOK 169 11.6 MIDDLE EAST & AFRICA 172 11.6.1 INCREASED INVESTMENTS IN HEALTHCARE TO PROPEL MARKET 172 11.6.2 MIDDLE EAST & NORTH AFRICA: MACROECONOMIC OUTLOOK 173 11.7 GCC COUNTRIES 176 11.7.1 INCREASED GOVERNMENT INVESTMENTS AND GROWING ADVANCEMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET 176 11.7.2 GCC COUNTRIES: MACROECONOMIC OUTLOOK 176 12 COMPETITIVE LANDSCAPE 180 12.1 OVERVIEW 180 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 180 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ACL GRAFT MARKET 180 12.3 REVENUE ANALYSIS 181 12.4 MARKET SHARE ANALYSIS 182 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 183 12.5.1 STARS 183 12.5.2 EMERGING LEADERS 183 12.5.3 PERVASIVE PLAYERS 183 12.5.4 PARTICIPANTS 183 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 185 12.5.5.1 Company footprint 185 12.5.5.2 Type of ACL surgery footprint 185 12.5.5.3 Age group footprint 185 12.5.5.4 Injury type footprint 186 12.5.5.5 End user footprint 186 12.5.5.6 Region footprint 186 12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 187 12.6.1 PROGRESSIVE COMPANIES 187 12.6.2 RESPONSIVE COMPANIES 187 12.6.3 DYNAMIC COMPANIES 187 12.6.4 STARTING BLOCKS 187 12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 189 12.7 PRODUCT COMPARISON 190 12.8 COMPETITIVE SCENARIO 190 12.8.1 PRODUCT LAUNCHES 190 13 COMPANY PROFILES 191 13.1 KEY PLAYERS 191 13.1.1 ALLOSOURCE 191 13.1.1.1 Business overview 191 13.1.1.2 Products offered 191 13.1.1.3 Recent developments 192 13.1.1.3.1 Product launches 192 13.1.1.4 MnM view 192 13.1.1.4.1 Key strengths 192 13.1.1.4.2 Strategic choices 192 13.1.1.4.3 Weakness and competitive threats 192 13.1.2 RTI SURGICAL 193 13.1.2.1 Business overview 193 13.1.2.2 Products offered 193 13.1.2.3 MnM view 193 13.1.2.3.1 Right to win 193 13.1.2.3.2 Strategic choices 194 13.1.2.3.3 Weaknesses and competitive threats 194 13.1.3 MTF BIOLOGICS 195 13.1.3.1 Business overview 195 13.1.3.2 Products offered 195 13.1.3.3 MnM view 195 13.1.3.3.1 Right to win 195 13.1.3.3.2 Strategic choices 196 13.1.3.3.3 Weaknesses and competitive threats 196 13.1.4 LIFENET HEALTH 197 13.1.4.1 Business overview 197 13.1.4.2 Products offered 197 13.2 OTHER PLAYERS 198 13.2.1 ARTHREX INC. 198 13.2.2 PARAMETRICS MEDICAL 198 13.2.3 JRF ORTHO 199 13.2.4 CENOBIOLOGICS LTD 200 14 APPENDIX 201 14.1 DISCUSSION GUIDE 201 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 206 14.3 CUSTOMIZATION OPTIONS 208 14.4 RELATED REPORTS 208 14.5 AUTHOR DETAILS 209
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
MarketsandMarkets社のMedical Devices分野での最新刊レポート
本レポートと同じKEY WORD(graft)の最新刊レポートよくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/04 10:27 150.82 円 158.84 円 193.81 円 |